Life Tech Targets Oxford's $173M Royalty Claim
Life Technologies Corp. is seeking to invalidate an Oxford Biomedical Research Inc. patent at the heart of a $173 million contract dispute over the patent's method of purifying proteins in engineered...To view the full article, register now.
Already a subscriber? Click here to view full article